Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients
Recruiting
N/A
Interventional Study
Glioblastoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 36 (estimated)
- Sponsor
- University of Aarhus · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this phase 1 dose finding study is to to assess the clinical tolerability and safety of escalated dose proton therapy in glioblastoma patients treated with multimodality treatment, according to treatment volume.
The main questions it aims to answer are:
* what is the maximum tolerated proton dose in glioblastoma patients?
* is the maximum tolerated proton dose in glioblastoma patient…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria (main):
* Newly diagnosed, contrast-enhancing GBM, IDHwt (WHO 2021 classification).
* Maximal safe surgical resection is required; any extent of surgical resection is allowed (including biopsy-only).
* Patient with target volume and location eligible for 60 Gy chemoradiotherapy.
…
Contacts